| Abbreviation | Full Term |
| AI | Artificial Intelligence |
| ML | Machine Learning |
| DL | Deep Learning |
| RCT | Randomized Controlled Trial |
| RoB 2 | Risk of Bias 2 Tool |
| ROBINS-I | Risk Of Bias In Non-randomized Studies—of Interventions |
| PICOS | Population, Intervention, Comparison, Outcomes, Study Design |
| HbA1c | Glycated Hemoglobin |
| HOMA-IR | Homeostatic Model Assessment of Insulin Resistance |
| QoL | Quality of Life |
| CKD | Chronic Kidney Disease |
| T1D | Type 1 Diabetes |
| T2D | Type 2 Diabetes |
| IBS | Irritable Bowel Syndrome |
| IBS-M | Irritable Bowel Syndrome—Mixed subtype |
| IBS-SSS | Irritable Bowel Syndrome Severity Scoring System |
| FODMAP | Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols |
| MedDiet | Mediterranean Diet |
| CBMpW | Complete Bowel Movements per Week |
| LDL-C | Low-Density Lipoprotein Cholesterol |
| ICER | Incremental Cost-Effectiveness Ratio |
| mHealth | Mobile Health |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |